Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
518,5 USD | -0,27% | +0,75% | +9,96% |
18/03 | Kroger verkoopt speciaalzaak aan CarelonRx van Elevance Health | RE |
18/03 | Kroger gaat specialistische apotheekactiviteiten verkopen aan Elevance Health | MT |
Omzet 2024 * | 172 mld. 159 mld. | Omzet 2025 * | 182 mld. 169 mld. | Marktkapitalisatie | 121 mld. 112 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 8,22 mld. 7,62 mld. | Nettowinst (verlies) 2025 * | 9,09 mld. 8,42 mld. | EV/omzet 2024 * | 0,79 x |
Nettoschuld 2024 * | 14,51 mld. 13,45 mld. | Nettoschuld 2025 * | 11,06 mld. 10,25 mld. | EV/omzet 2025 * | 0,72 x |
K/w-verhouding 2024 * |
15
x | K/w-verhouding 2025 * |
13,2
x | Werknemers | 104.900 |
Dividendrendement 2024 * |
1,21% | Dividendrendement 2025 * |
1,28% | Vrij verhandelbaar | 99,51% |
Recentste transcriptie over Elevance Health, Inc.
1 dag | -0,27% | ||
1 week | +0,75% | ||
Lopende maand | +3,45% | ||
1 maand | +3,07% | ||
3 maanden | +10,64% | ||
6 maanden | +15,93% | ||
Lopend jaar | +9,96% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20-11-17 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 06-09-23 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | 05/02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 75 | 01-10-13 | |
Director/Board Member | 56 | 01-11-22 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20-11-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
3.22% | 18 M€ | +6,77% | - | |
2.36% | 907 M€ | +9,60% | - | |
2.07% | 8 M€ | +6,91% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 518,5 | -0,27% | 875 607 |
27-03-24 | 520 | +0,53% | 685 889 |
26-03-24 | 517,2 | +1,35% | 983 117 |
25-03-24 | 510,4 | -0,68% | 572 163 |
22-03-24 | 513,8 | -0,16% | 608 550 |
uitgestelde koers Nyse, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,96% | 121 mld. | |
+21,29% | 103 mld. | |
-24,27% | 41,8 mld. | |
+5,75% | 41,98 mld. | |
+13,71% | 24,07 mld. | |
+2,61% | 3,68 mld. | |
-42,39% | 937 mln. | |
-16,61% | 393 mln. |